InventisBio Past Earnings Performance
Past criteria checks 0/6
InventisBio has been growing earnings at an average annual rate of 9.2%, while the Biotechs industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 52.6% per year.
Key information
9.2%
Earnings growth rate
40.5%
EPS growth rate
| Biotechs Industry Growth | 11.3% |
| Revenue growth rate | 52.6% |
| Return on equity | -20.1% |
| Net Margin | -449.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How InventisBio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 78 | -348 | 77 | 390 |
| 30 Jun 24 | 120 | -330 | 71 | 415 |
| 31 Mar 24 | 194 | -249 | 68 | 417 |
| 31 Dec 23 | 186 | -284 | 70 | 443 |
| 30 Sep 23 | 127 | -340 | 60 | 433 |
| 30 Jun 23 | 80 | -426 | 63 | 480 |
| 31 Mar 23 | 0 | -481 | 59 | 464 |
| 31 Dec 22 | 0 | -483 | 58 | 461 |
| 30 Sep 22 | 0 | -476 | 54 | 449 |
| 30 Jun 22 | 0 | -416 | 49 | 386 |
| 31 Mar 22 | 0 | -411 | 51 | 358 |
| 31 Dec 21 | 0 | -358 | 48 | 315 |
| 31 Dec 20 | 0 | -1,053 | 24 | 1,005 |
| 31 Dec 19 | 55 | -95 | 12 | 131 |
Quality Earnings: 688382 is currently unprofitable.
Growing Profit Margin: 688382 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688382 is unprofitable, but has reduced losses over the past 5 years at a rate of 9.2% per year.
Accelerating Growth: Unable to compare 688382's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 688382 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (0.08%).
Return on Equity
High ROE: 688382 has a negative Return on Equity (-20.06%), as it is currently unprofitable.